Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportRadiopharmaceutical Chemistry: New Radiopharmaceuticals-Novel Probe Development

Synthesis of optically pure 4-fluoro-L-glutamines as potential tumor imaging agents

Wenchao Qu, Zhihao Zha, Karl Ploessl, Brian Lieberman, Lin Zhu, David Wise, Craig Thompson and Hank Kung
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1507;
Wenchao Qu
1Radiology, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhihao Zha
1Radiology, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karl Ploessl
1Radiology, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian Lieberman
1Radiology, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lin Zhu
1Radiology, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Wise
2Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Craig Thompson
2Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hank Kung
1Radiology, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 51 no. supplement 2 1507

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 3, 2014.

Copyright & Usage 
© 2010

Author Information

  1. Wenchao Qu1,
  2. Zhihao Zha1,
  3. Karl Ploessl1,
  4. Brian Lieberman1,
  5. Lin Zhu1,
  6. David Wise2,
  7. Craig Thompson2 and
  8. Hank Kung1
  1. 1Radiology, University of Pennsylvania, Philadelphia, PA
  2. 2Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: November 2014 to April 2025

AbstractFullPdf
Nov 2014300
Jun 2015200
Aug 2015200
Sep 2015400
Dec 2015700
Mar 2016100
Jun 2016400
Jul 2016500
Aug 2016200
Sep 2016500
Oct 2016400
Nov 2016400
Dec 2016900
Jan 2017600
Feb 2017700
Mar 2017500
Apr 2017800
May 2017600
Jun 2017700
Jul 2017600
Aug 2017600
Sep 2017500
Oct 2017900
Nov 2017400
Jan 2018200
Feb 2018200
Mar 2018500
Apr 2018600
May 20181800
Jun 20181500
Jul 20181100
Aug 2018500
Sep 20181800
Oct 20182600
Nov 20182200
Dec 20182500
Jan 20192300
Feb 20191800
Mar 20191700
Apr 20191900
May 2019200
Jun 2019500
Jul 2019800
Aug 2019500
Oct 2019500
Dec 2019100
Jan 2020100
Feb 2020700
Mar 20201400
Apr 20201000
Jun 2020100
Jul 2020200
Aug 20209300
Sep 202012600
Oct 20201100
Nov 20202500
Dec 2020800
Jan 2021500
Feb 20212200
Mar 20211500
Apr 20211000
May 2021600
Jun 2021500
Jul 20211400
Aug 20213600
Sep 20211100
Oct 20211100
Nov 20217400
Dec 20214300
Jan 20227200
Feb 20221900
Mar 20221600
Apr 2022700
May 20222600
Jun 2022100
Jul 2022100
Aug 2022100
Sep 2022100
Oct 2022200
Nov 2022200
Dec 2022100
Jan 2023100
Feb 2023100
Mar 2023100
May 2023300
Jun 2023400
Jul 2023400
Aug 2023200
Sep 2023300
Oct 2023500
Nov 2023200
Dec 2023800
Jan 2024500
Feb 2024400
Mar 2024300
Apr 2024500
May 2024400
Jun 2024600
Jul 2024400
Aug 20241000
Sep 2024200
Oct 2024600
Nov 2024500
Dec 2024900
Feb 2025200
Mar 2025600
Apr 2025500
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 51, Issue supplement 2
May 2010
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Synthesis of optically pure 4-fluoro-L-glutamines as potential tumor imaging agents
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Synthesis of optically pure 4-fluoro-L-glutamines as potential tumor imaging agents
Wenchao Qu, Zhihao Zha, Karl Ploessl, Brian Lieberman, Lin Zhu, David Wise, Craig Thompson, Hank Kung
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1507;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Synthesis of optically pure 4-fluoro-L-glutamines as potential tumor imaging agents
Wenchao Qu, Zhihao Zha, Karl Ploessl, Brian Lieberman, Lin Zhu, David Wise, Craig Thompson, Hank Kung
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1507;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Radiopharmaceutical Chemistry: New Radiopharmaceuticals-Novel Probe Development

  • Evaluation of 123I-ICdR as a novel SPECT proliferation probe in a sarcoma-bearing mouse model
  • Iodine-131 D-amino acid peptide, a novel bi-functional chelating agent for improving therapeutic application of Rituximab
  • [11C]Dimebon as a new PET agent for imaging of Alzheimer’s disease and Huntington’s disease
Show more Radiopharmaceutical Chemistry: New Radiopharmaceuticals-Novel Probe Development

New Radiopharmaceuticals-Novel Probe Development Posters

  • Iodine-131 D-amino acid peptide, a novel bi-functional chelating agent for improving therapeutic application of Rituximab
  • [11C]Dimebon as a new PET agent for imaging of Alzheimer’s disease and Huntington’s disease
  • 18F-Peptide probe for PET imaging of VEGF expression
Show more New Radiopharmaceuticals-Novel Probe Development Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire